NCT04912609View on ClinicalTrials.gov

Trehalose Administration in Subjects With Spastic Paraplegia 11 (3AL-SPG11)

CompletedOBSERVATIONAL

Enrollment

13

Participants

Timeline

Start Date

June 30, 2021

Primary Completion Date

April 30, 2022

Study Completion Date

July 30, 2022

Conditions

Hereditary Spastic ParaplegiaSpastic Paraplegia Type 11

Trial Locations (1)

56128

IRCCS Fondazione Stella Maris, Pisa

All Listed Sponsors

lead

IRCCS Fondazione Stella Maris

OTHER